FORESEE PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95 TWD | -0.11% |
|
+1.50% | -1.25% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Foresee Pharmaceuticals Co., Ltd. is a Taiwan-based company mainly engaged in the research and development of new pharmaceuticals. The Company's main products include prostate cancer treatment product FP-001 and asthmatic/chronic obstructive pulmonary disease treatment product FP-025. It also engages in new pharmaceuticals clinic trial business.
Calendar
2024-05-09
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
95
TWD
Average target price
153
TWD
Spread / Average Target
+61.05%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -1.25% | 396M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- 6576 Stock
- News Foresee Pharmaceuticals Co., Ltd.
- Foresee Pharmaceuticals to Present Allergic Asthma Study at European Medical Conference
